bs-60149C [Life Science]
FLI-06 --- Notch Pathway Modulator
www.biossusa.com
[email protected]
800.501.7654 [DOMESTIC]
+1.781.569.5821 [INTERNATIONAL]
DATASHEET

Formulation Powder

Storage: Store in dry, dark place at -20C for 1 year.

Product Information:

Molecular Weight: 438.52

Formula: C25 H30 N2 O5

CAS Number: 313967-18-9

InChi Key: SWWVFYHSSOWZMF-UHFFFAOYSA-N

InChi: InChI=1S/C25H30N2O5/c1-15-21(24(29)32-18-7-5-4-6-8-18)22(16-9-11-17(12-10-16)27(30)31)23-19(26-15)13-25(2,3)14-20(23)28/h9-12,18,22,26H,4-8,13-14H2,1-3H3

Smiles: CC1NC2CC(C)(C)CC(=O)C=2C(C=1C(=O)OC1CCCCC1)C1C=CC(=CC=1)[N+]([O-])=O

Purity: 98.0

Solubility: DMSO up to 50 mM

Appearance: Solid Power.

Shelf Life: 1.0 years

Description:

FLI-06 is a novel potent and selective small molecule intercepting Notch signaling and the early secretory pathway (EC50 ~2.3 µM), identified by using automated microscopy to monitor the trafficking and processing of a ligand-independent Notch-GFP fusion reporter. FLI-06 can induce accumulation of the reporter at the plasma membrane by interfering with transport in the secretory pathway. It can also disrupt the Golgi apparatus in a manner distinct from that of brefeldin A and golgicide A. FLI-06 inhibited general secretion at a step before exit from the endoplasmic reticulum (ER), which was accompanied by a tubule-to-sheet morphological transition of the ER, rendering FLI-06 the first small molecule acting at such an early stage in secretory traffic. FLI-06 is a very useful chemical probe to study the inhibition of membrane traffic at pre- ER-exit site (ERES) stages without fusion of ER-Golgi.

Size: 10mg solid, 2mg solid , 10 mM in DMSO (0.45610mg solid, 2mg solid , 10 mM in DMSO (0.456 mL)

Applications: Life Science()

For research use only. Not intended for diagnostic or therapeutic use.